Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Genetic correlates of morphine withdrawal in 14 inbred mouse strains.

Metten P, Crabbe JC, Belknap JK.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):123-31. doi: 10.1016/j.drugalcdep.2008.07.006. Epub 2008 Sep 6.

3.
4.

Quantitative opioid withdrawal signs in rats: effects exerted by clothiapine administration.

Pinelli A, Trivulzio S, Ciapponi PM.

Fundam Clin Pharmacol. 1997;11(4):346-55.

PMID:
9263765
5.

Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.

Shoblock JR, Maidment NT.

Neuroscience. 2007 Nov 9;149(3):642-9. Epub 2007 Oct 1.

PMID:
17905519
6.

In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Singh P, Sharma B, Gupta S, Sharma BM.

Psychopharmacology (Berl). 2015 Jan;232(2):465-75. doi: 10.1007/s00213-014-3680-5. Epub 2014 Jul 26.

PMID:
25059539
7.
8.

Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.

Pinelli A, Trivulzio S, Spezia R.

Drug Alcohol Depend. 1998 Mar 1;50(1):81-8.

PMID:
9589275
9.

Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.

Pinelli A, Trivulzio S, Tomasoni L.

Eur J Pharmacol. 1997 Dec 11;340(2-3):111-9.

PMID:
9537805
10.

The role of cholinergic systems in the expression of morphine withdrawal.

Sharif SI, el-Kadi AO.

Neurosci Res. 1996 Jun;25(2):155-60.

PMID:
8829152
12.

Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.

Rehni AK, Bhateja P, Singh TG, Singh N.

Behav Pharmacol. 2008 May;19(3):265-9. doi: 10.1097/FBP.0b013e3282febcd9.

PMID:
18469544
13.

Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".

Fdez Espejo E, Cador M, Stinus L.

Psychopharmacology (Berl). 1995 Nov;122(2):122-30.

PMID:
8848527
14.
15.

Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.

Nakagawa T, Minami M, Katsumata S, Ienaga Y, Satoh M.

Br J Pharmacol. 1995 Nov;116(6):2661-6.

16.

Suppressive effects of dichloromethane fraction from the Areca catechu nut on naloxone-precipitated morphine withdrawal in mice.

Kumarnsit E, Keawpradub N, Vongvatcharanon U, Sawangjaroen K, Govitrapong P.

Fitoterapia. 2005 Sep;76(6):534-9.

PMID:
15993008
17.

ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.

Brugger S, Sánchez R, Brugger AJ, Martinez JA.

Prog Neuropsychopharmacol Biol Psychiatry. 1998 Jul;22(5):775-85.

PMID:
9723119
18.
19.

Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.

Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB.

Neurosci Lett. 2010 Jan 14;468(3):348-52. doi: 10.1016/j.neulet.2009.11.030. Epub 2009 Nov 14.

PMID:
19922770

Supplemental Content

Support Center